• Nachrichtendetail
• 

18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	MERCK CO. DL-,01	A0YD8Q	Xetra	103,800	21.08.24 12:09:05	+0,400	+0,39%	103,600	103,800	103,600	103,400
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	93,500	21.08.24 08:39:33	+1,000	+1,08%	93,000	94,500	93,500	92,500